OncoLens
Developer of a HIPAA-compliant mobile and web-based platform designed for targeted treatment planning and confident clinical decision-making. The company's platform brings disparate data sets, oncolog...
Valuation
$54M
Latest known
Share Price
N/A
Total Raised
$22.9M
Last Round
N/A